Jaclyn Malmed is a member of the intellectual property transactions group in Ropes & Gray's New York office. She advises clients across a broad range of industries, including consumer brands, technology and software, media and entertainment, health care, private equity, and other financial services. Her practice typically focuses on strategic arrangements that involve the creation, transfer, licensing, or securitization of intellectual property assets.
Jaclyn regularly assists private equity firms, lenders, and other companies on corporate and strategic transactions involving intellectual property and technology, with a focus on mergers and acquisitions, complex carve-outs, divestitures, investments, restructurings, whole business securitizations, and licensing arrangements. Jaclyn also brings substantive and practical insight, particularly in the areas of trademarks and brand protection, software, and cloud-based technologies.
Prior to joining Ropes & Gray, Jaclyn was an associate in the intellectual property, sourcing & technology group at another international law firm.
Experience
- Represented DIRECTV in an agreement to acquire EchoStar's video distribution business DISH, including DISH TV and Sling TV, through a debt exchange transaction.
- Represented THL Partners in its majority investment in AMI, a provider of silicon level software required to power and boot, manage, orchestrate, and secure modern computing environments.
- Represented a global leader in medical technologies, in an agreement to acquire a private company specializing in delivering AI-assisted virtual care workflows and smart room technology.
- Represented Genstar Capital in a significant investment in AffiniPay, a leading provider of practice management software, integrated payments and embedded fintech for the legal, accounting and professional services end markets.
- Represented Amylyx Pharmaceuticals in acquiring a first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist, avexitide, from Eiger BioPharmaceuticals that is ready for Phase 3 trials for post-bariatric hypoglycemia (PBH), a common complication of bariatric surgery, and congenital hyperinsulinism (HI).
- Represented Compass Diversified in its definitive agreement to partner with feminine care brand The Honey Pot Company for an enterprise value of $380 million.
- Represented LianBio in a licensing agreement with Janssen Pharmaceuticals, a Johnson & Johnson company, in which LianBio has assigned to Janssen Lian’s exclusive rights to develop and commercialize a first-in class investigational radioenhancer activated by radiotherapy, NBTXR3, in China, South Korea, Singapore and Thailand.
- Represented Lee Equity Partners, LLC in the acquisition of Carisk® Partners, a specialty risk transfer and care coordination company serving insurers, government entities, self-insured plan sponsors and other managed care organizations.
- Represented Bain Capital
- in the sale of its portfolio company HealthDrive to private investment firm, Cressey & Company; and
- in its strategic growth investment in Ren, an Indianapolis-based technology provider for financial institutions and nonprofit organizations.
- Represented FB Debt Financing Guarantor, LLC and certain of its subsidiaries, a producer of top beauty brands including Morphe®, Morphe 2®, Jaclyn Cosmetics®, and Born Dreamer®, in their 363 carve-out sale of the r.e.m. beauty business to an entity associated with Ariana Grande, AGREM BTY, LLC.
- Represented GreenSlate Holdings LLC in a strategic investment made by Francisco Partners and VSS Capital Partners.
- Represented Planview in its acquisitions of Tasktop, a pioneer and leader in Value Stream Management (VSM), and Enrich, a product portfolio analytics company.
- Represented Pfizer, Inc. in its entry into a definitive agreement to acquire Biohaven Pharmaceuticals, the maker of NURTEC ODT, an innovative dual-acting migraine therapy approved for both acute treatment and episodic prevention of migraine in adults.
- Represented BV Investment Partners:
- in its acquisition of Source Advisors, a market leading specialty tax solutions and software provider;
- its investment in Hardenbergh Group, a nationwide provider of non-clinical professional staffing, consulting, physician peer review and outsourced solutions to healthcare organizations; and
- oon the closing of a single-asset continuation fund transaction for Right Networks, a premier provider of cloud solutions to tax and accounting firms.
- Represented Goddard Schools, Zaxby’s and Authority Brands in connection with the intellectual property and licensing aspects of their whole-business securitizations and follow-on offerings.